Snapshot from Jun 28, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Levi Garraway
Person

Levi Garraway

Tracked across 1 events · 6 articles · First seen Apr 21, 2026 · Last active Jun 11, 2026

Sentiment
0
Attention
4
Events
1
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 0
Regulatory
FDA accepts Roche Tecentriq sBLA
Roche>>> announced that the United States — Food and Drug Administration>>> has accepted its supplemental Biologics License Application (sBLA) for adjuvant Atezolizumab>>> and Atezolizumab Hybreza in combination with chemotherapy for stage III deficient DNA mismatch…
Impact: Levi Garraway>>>, Roche>>>'s Chief Medical Officer, commented on the significance of the filing acceptance for Atezolizumab>>>.
Jun 11, 2026 · 6 articles
Relationships (2)
Roche ↔ Levi Garraway
Roche ↔ Levi Garraway
NEWSDESK
Track Levi Garraway live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.